Monopar Therapeutics ($MNPR)
Filing Information
| Accession Number | 0001437749-26-029121 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 27, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
2,761
Total Value
$118.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acting Chief Medical Officer | Common Stock | โ | Aug 26, 2026 | Exercise/Conversion | 1,380 | $0.01 | $6.90 | 5,066 | Direct | โ | View Details | |
Acting Chief Medical Officer | Common Stock | โ | Aug 26, 2026 | Sale | 1 | $111.26 | $111.26 | 5,065 | Direct | โ | View Details | |
Acting Chief Medical Officer | Stock Option | Derivative | Aug 26, 2026 | Exercise/Conversion | 1,380 | $0.00 | $0.00 | 0 | Direct | โ | View Details |